Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ADALIMUMAB-ADAZ 40 MG/0.4 ML SUBCUTANEOUS PEN INJECTOR (NDC 61314047320) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 28, 2026 , from http://ppman.hank.ai/transparency/procedure/61314047320/by-state?code_type=NDC
“ADALIMUMAB-ADAZ 40 MG/0.4 ML SUBCUTANEOUS PEN INJECTOR (NDC 61314047320) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/61314047320/by-state?code_type=NDC. Accessed
October 28, 2026 .
“ADALIMUMAB-ADAZ 40 MG/0.4 ML SUBCUTANEOUS PEN INJECTOR (NDC 61314047320) by State,” HANK Price Transparency ,
accessed October 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/61314047320/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
61314047320 — Adalimumab-adaz 40 Mg/0.4 Ml Subcutaneous Pen Injector
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$22,481
National median
$17,868 – $38,120
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 61314047320 (NDC), with interquartile range
State Median p25 p75
TX $22,481 $17,868 $38,120